サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1705386

マイクロRNAの世界市場レポート2025

MicroRNA Global Market Report 2025

出版日
ページ情報
英文 200 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
マイクロRNAの世界市場レポート2025
出版日: 2025年04月01日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

マイクロRNA市場規模は、今後数年で急成長が見込まれます。2029年には31億1,000万米ドルに成長し、CAGRは18.5%となります。予測期間の成長は、臨床応用、レギュラトリーネットワークとシステム生物学、マイクロRNAに基づく治療薬、治療可能性、バイオマーカー探索に起因しています。予測期間における主な動向としては、技術の進歩、バイオインフォマティクスとデータ解析、種を超えた保存、マイクロバイオーム相互作用、機能的メカニズムなどが挙げられます。

がん罹患率の上昇が、当面のマイクロRNA市場の拡大を牽引する見通しです。がんは、制御不能な細胞増殖を特徴とする多面的な疾患であり、しばしば悪性腫瘍の開発に至り、近隣組織に浸潤して遠隔臓器に転移し、重大な健康被害をもたらします。がん患者数の増加は、高齢化、喫煙や不健康な食生活などの生活習慣、環境毒素、早期発見を容易にする診断技術の向上など、さまざまな要因に起因しています。miRNAは、従来のがん治療と組み合わせることで、薬剤感受性を増強し、治療成績を向上させる。治療以外にも、miRNAは診断や予後のバイオマーカーとして機能し、がん種の同定、予後の予測、治療効果のモニタリングに役立ちます。例えば、2024年5月に米国国立がん研究所が報告したところによると、2022年には年間推定2,000万人の新規がん症例と970万人のがん関連死が発生し、2040年には年間1,530万人の死亡と2,990万人の新規症例に増加すると予測されています。その結果、がん罹患率の増加がマイクロRNA市場の成長を後押ししています。

マイクロRNA市場の有力企業は、研究者や臨床医の特定の要求に応え、miRNAの検出精度を高め、多様なアプリケーションを促進するために、MiRNAプローブのカスタマイズサービスなどの最先端ソリューションの開発に力を注いでいます。MiRNAプローブカスタマイズサービスは、バイオテクノロジーおよび分子生物学企業が、様々な研究および臨床目的のために、特定のマイクロRNA（miRNA）を標的とするオーダーメイドプローブを設計・製造するために提供する専門的なサービスを包含します。例えば、2023年9月、台湾のバイオテクノロジー企業Abnova Corporationは、miRNA研究に携わる学術界、産業界、研究界の多様なニーズに対応するため、カタログ化されたmiRNAプローブの新しい配列とともに、miRNAプローブのカスタマイズサービスの強化を発表しました。これらのプローブは、数多くの生物学的プロセスに不可欠な低分子ノンコーディングRNAであるmiRNAを同定し、正確に局在させる上で重要な役割を果たしています。Abnova社のカスタマイズサービスにより、高い特異性と最小限の交差反応性が保証されるため、miRNA含有量が限られているサンプルの分析にも適しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界マイクロRNA PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
  • 最終用途産業の分析
  • 世界のマイクロRNA市場：成長率分析
  • 世界のマイクロRNA市場の実績：規模と成長, 2019-2024
  • 世界のマイクロRNA市場の予測：規模と成長, 2024-2029, 2034F
  • 世界マイクロRNA総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界のマイクロRNA市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 機器
  • 消耗品
  • 世界のマイクロRNA市場アッセイタイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 免疫測定
  • 次世代シーケンシング
  • miRNAアレイ
  • ポリメラーゼ連鎖反応（PCR）ベースのアレイ
  • 世界のマイクロRNA市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • がん
  • 感染症
  • 免疫疾患
  • 心血管疾患
  • 神経疾患
  • その他の用途
  • 世界のマイクロRNA市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 学術研究機関
  • バイオ医薬品企業
  • 診断センター
  • 臨床調査機関
  • 世界のマイクロRNA市場、楽器の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • QPCRシステム（定量PCR）
  • マイクロアレイプラットフォーム
  • 次世代シーケンシング（NGS）システム
  • リアルタイムPCR装置
  • マイクロRNAアナライザー
  • 世界のマイクロRNA市場消耗品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • マイクロRNAキット（抽出キット、検出キット）
  • PCR試薬
  • プライマーとプローブ
  • マイクロアレイとチップ
  • RNAシーケンシングキット

第7章 地域別・国別分析

  • 世界のマイクロRNA市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界のマイクロRNA市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • マイクロRNA市場：競合情勢
  • マイクロRNA市場：企業プロファイル
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc Overview, Products and Services, Strategy and Financial Analysis
    • Kaneka Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Bio-Rad Laboratories Inc.
  • QIAGEN N.V.
  • Miltenyi Biotec
  • LGC Limited
  • Promega Corporation
  • Abcam plc
  • Integrated DNA Technologies Inc.
  • NanoString Technologies Inc.
  • Biodynamics Laboratory Inc.
  • Horizon Discovery Ltd.
  • OriGene Technologies Inc.
  • Biogenex Laboratories
  • Omega Bio-Tek
  • New England Biolabs
  • Quantabio

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • マイクロRNA市場2029：新たな機会を提供する国
  • マイクロRNA市場2029：新たな機会を提供するセグメント
  • マイクロRNA市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r30696

MicroRNAs, small RNA molecules that do not code for proteins and typically span about 20-22 nucleotides in length, serve as regulators of gene expression. They achieve this by binding to complementary sequences on messenger RNA (mRNA) molecules, typically resulting in gene silencing through translational repression or target degradation.

The primary products related to microRNAs include instruments and consumables. MicroRNA instruments encompass the tools and equipment utilized for microRNA analysis, such as microarray scanners and PCR machines. Various assay types involved include immunoassays, next-generation sequencing, miRNA arrays, and PCR-based arrays, applied in cancer, infectious diseases, immunological disorders, cardiovascular diseases, neurological diseases, and other applications. These are employed by academic and research institutes, biopharmaceutical companies, diagnostic centers, and clinical research organizations.

The microRNA market research report is one of a series of new reports from The Business Research Company that provides microRNA market statistics, including microRNA industry global market size, regional shares, competitors with microRNA market share, detailed microRNA market segments, market trends, and opportunities, and any further data you may need to thrive in the microRNA industry. This microRNA market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The microrna market size has grown rapidly in recent years. It will grow from $1.33 billion in 2024 to $1.58 billion in 2025 at a compound annual growth rate (CAGR) of 18.9%. The growth in the historic period can be attributed to discovery of microRNAs, RNA interference (RNAi), genome sequencing projects, computational biology and bioinformatics, and extracellular vehicles (EVs) research.

The microrna market size is expected to see rapid growth in the next few years. It will grow to $3.11 billion in 2029 at a compound annual growth rate (CAGR) of 18.5%. The growth in the forecast period can be attributed to clinical translation, regulatory networks and systems biology, microRNA-based therapeutics, therapeutic potential, and biomarker discovery. Major trends in the forecast period include technological advances, bioinformatics and data analysis, cross-species conservation, microbiome interactions, and functional mechanisms.

The rising incidence of cancer cases is poised to drive the expansion of the microRNA market in the foreseeable future. Cancer, a multifaceted ailment characterized by uncontrolled cell proliferation, often culminates in the development of malignant tumors that can infiltrate nearby tissues and metastasize to distant organs, posing significant health hazards. The escalating number of cancer cases stems from diverse factors, including aging demographics, lifestyle behaviors such as smoking and unhealthy dietary habits, environmental toxins, and enhanced diagnostic techniques facilitating early detection. MicroRNA, when combined with conventional cancer treatments, augments drug sensitivity and enhances treatment outcomes. Beyond therapy, miRNAs function as diagnostic and prognostic biomarkers, aiding in cancer type identification, prognosis prediction, and treatment response monitoring. For example, in May 2024, as reported by the National Cancer Institute, an estimated 20 million new cancer cases and 9.7 million cancer-related deaths occurred annually in 2022, with projections indicating a rise to 15.3 million deaths and 29.9 million new cases per year by 2040. Consequently, the mounting incidence of cancer cases propels the growth of the microRNA market.

Prominent entities in the microRNA market are directing their efforts towards developing cutting-edge solutions, such as MiRNA probe customization services, to cater to the specific requirements of researchers and clinicians, enhance miRNA detection accuracy, and facilitate diverse applications. MiRNA probe customization services encompass specialized offerings provided by biotechnology and molecular biology firms to design and manufacture tailored probes targeting specific microRNAs (miRNAs) for various research and clinical purposes. For instance, in September 2023, Abnova Corporation, a biotechnology firm based in Taiwan, introduced enhanced services for customizing miRNA probes alongside a new array of cataloged miRNA probes to address the varied needs of academic, industrial, and research communities involved in miRNA studies. These probes play a critical role in identifying and precisely localizing miRNAs, which are small, non-coding RNA molecules essential for numerous biological processes. Abnova's customization services ensure high specificity and minimal cross-reactivity, rendering them suitable for analyzing samples with limited miRNA content.

In May 2024, Bruker Corporation, a US-based scientific instruments company, acquired NanoString Technologies Inc. for approximately $392.6 million. This acquisition is intended to strengthen Bruker's capabilities in gene expression profiling and spatial transcriptomics, reinforcing its position in the life sciences research market. NanoString Technologies Inc., also based in the United States, is a biotechnology company specializing in solutions for gene expression analysis.

Major companies operating in the MicroRNA market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc, Kaneka Corporation, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Miltenyi Biotec, LGC Limited, Promega Corporation, Abcam plc, Integrated DNA Technologies Inc., NanoString Technologies Inc., Biodynamics Laboratory Inc., Horizon Discovery Ltd., OriGene Technologies Inc., Biogenex Laboratories, Omega Bio-Tek, New England Biolabs, Quantabio, SeqMatic LLC, GeneCopoeia Inc., HTG Molecular Diagnostics Inc., Synlogic Inc, Sistemic Scotland Limited

North America was the largest region in the microRNA market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the MicroRNA market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the MicroRNA market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The microRNA market consists of revenues earned by entities by providing services such as microRNA sequencing and data analysis services, microRNA therapeutic development services, and microRNA profiling services. The market value includes the value of related goods sold by the service provider or included within the service offering. The microRNA market also includes sales of microRNA extraction kits, microRNA detection kits, microRNA quantification kits, and microRNA expression arrays. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

MicroRNA Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on microrna market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for microrna ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The microrna market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Products: Instruments; Consumables
  • 2) By Assay Type: Immunoassay; Next Generation Sequencing; miRNA Arrays; Polymerase Chain Reaction (PCR) Based Arrays
  • 3) By Application: Cancer; Infectious Diseases; Immunological Disorder; Cardiovascular Disease; Neurological Disease; Other Applications
  • 4) By End User: Academic And Research Institutes; Biopharmaceutical Companies; Diagnostic Centers; Clinical Research Organizations
  • Subsegments:
  • 1) By Instruments: Qpcr Systems (Quantitative Pcr); Microarray Platforms; Next-Generation Sequencing (Ngs) Systems; Real-Time Pcr Instruments; Microrna Analyzers
  • 2) By Consumables: Microrna Kits ( Extraction Kits, Detection Kits); Pcr Reagents; Primers And Probes; Microarrays And Chips; Rna Sequencing Kits
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Agilent Technologies Inc; Kaneka Corporation; Illumina Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. MicroRNA Market Characteristics

3. MicroRNA Market Trends And Strategies

4. MicroRNA Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global MicroRNA Growth Analysis And Strategic Analysis Framework

  • 5.1. Global MicroRNA PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global MicroRNA Market Growth Rate Analysis
  • 5.4. Global MicroRNA Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global MicroRNA Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global MicroRNA Total Addressable Market (TAM)

6. MicroRNA Market Segmentation

  • 6.1. Global MicroRNA Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Consumables
  • 6.2. Global MicroRNA Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immunoassay
  • Next Generation Sequencing
  • miRNA Arrays
  • Polymerase Chain Reaction (PCR) Based Arrays
  • 6.3. Global MicroRNA Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer
  • Infectious Diseases
  • Immunological Disorder
  • Cardiovascular Disease
  • Neurological Disease
  • Other Applications
  • 6.4. Global MicroRNA Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Academic And Research Institutes
  • Biopharmaceutical Companies
  • Diagnostic Centers
  • Clinical Research Organizations
  • 6.5. Global MicroRNA Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • QPCR Systems (Quantitative PCR)
  • Microarray Platforms
  • Next-Generation Sequencing (NGS) Systems
  • Real-Time PCR Instruments
  • MicroRNA Analyzers
  • 6.6. Global MicroRNA Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • MicroRNA Kits (Extraction Kits, Detection Kits)
  • PCR Reagents
  • Primers And Probes
  • Microarrays And Chips
  • RNA Sequencing Kits

7. MicroRNA Market Regional And Country Analysis

  • 7.1. Global MicroRNA Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global MicroRNA Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific MicroRNA Market

  • 8.1. Asia-Pacific MicroRNA Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific MicroRNA Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific MicroRNA Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific MicroRNA Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China MicroRNA Market

  • 9.1. China MicroRNA Market Overview
  • 9.2. China MicroRNA Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China MicroRNA Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China MicroRNA Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India MicroRNA Market

  • 10.1. India MicroRNA Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India MicroRNA Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India MicroRNA Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan MicroRNA Market

  • 11.1. Japan MicroRNA Market Overview
  • 11.2. Japan MicroRNA Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan MicroRNA Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan MicroRNA Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia MicroRNA Market

  • 12.1. Australia MicroRNA Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia MicroRNA Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia MicroRNA Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia MicroRNA Market

  • 13.1. Indonesia MicroRNA Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia MicroRNA Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia MicroRNA Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea MicroRNA Market

  • 14.1. South Korea MicroRNA Market Overview
  • 14.2. South Korea MicroRNA Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea MicroRNA Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea MicroRNA Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe MicroRNA Market

  • 15.1. Western Europe MicroRNA Market Overview
  • 15.2. Western Europe MicroRNA Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe MicroRNA Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe MicroRNA Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK MicroRNA Market

  • 16.1. UK MicroRNA Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK MicroRNA Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK MicroRNA Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany MicroRNA Market

  • 17.1. Germany MicroRNA Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany MicroRNA Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany MicroRNA Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France MicroRNA Market

  • 18.1. France MicroRNA Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France MicroRNA Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France MicroRNA Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy MicroRNA Market

  • 19.1. Italy MicroRNA Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy MicroRNA Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy MicroRNA Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain MicroRNA Market

  • 20.1. Spain MicroRNA Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain MicroRNA Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain MicroRNA Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe MicroRNA Market

  • 21.1. Eastern Europe MicroRNA Market Overview
  • 21.2. Eastern Europe MicroRNA Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe MicroRNA Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe MicroRNA Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia MicroRNA Market

  • 22.1. Russia MicroRNA Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia MicroRNA Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia MicroRNA Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America MicroRNA Market

  • 23.1. North America MicroRNA Market Overview
  • 23.2. North America MicroRNA Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America MicroRNA Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America MicroRNA Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA MicroRNA Market

  • 24.1. USA MicroRNA Market Overview
  • 24.2. USA MicroRNA Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA MicroRNA Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA MicroRNA Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada MicroRNA Market

  • 25.1. Canada MicroRNA Market Overview
  • 25.2. Canada MicroRNA Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada MicroRNA Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada MicroRNA Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America MicroRNA Market

  • 26.1. South America MicroRNA Market Overview
  • 26.2. South America MicroRNA Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America MicroRNA Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America MicroRNA Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil MicroRNA Market

  • 27.1. Brazil MicroRNA Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil MicroRNA Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil MicroRNA Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East MicroRNA Market

  • 28.1. Middle East MicroRNA Market Overview
  • 28.2. Middle East MicroRNA Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East MicroRNA Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East MicroRNA Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa MicroRNA Market

  • 29.1. Africa MicroRNA Market Overview
  • 29.2. Africa MicroRNA Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa MicroRNA Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa MicroRNA Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. MicroRNA Market Competitive Landscape And Company Profiles

  • 30.1. MicroRNA Market Competitive Landscape
  • 30.2. MicroRNA Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Agilent Technologies Inc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Kaneka Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. MicroRNA Market Other Major And Innovative Companies

  • 31.1. Bio-Rad Laboratories Inc.
  • 31.2. QIAGEN N.V.
  • 31.3. Miltenyi Biotec
  • 31.4. LGC Limited
  • 31.5. Promega Corporation
  • 31.6. Abcam plc
  • 31.7. Integrated DNA Technologies Inc.
  • 31.8. NanoString Technologies Inc.
  • 31.9. Biodynamics Laboratory Inc.
  • 31.10. Horizon Discovery Ltd.
  • 31.11. OriGene Technologies Inc.
  • 31.12. Biogenex Laboratories
  • 31.13. Omega Bio-Tek
  • 31.14. New England Biolabs
  • 31.15. Quantabio

32. Global MicroRNA Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The MicroRNA Market

34. Recent Developments In The MicroRNA Market

35. MicroRNA Market High Potential Countries, Segments and Strategies

  • 35.1 MicroRNA Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 MicroRNA Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 MicroRNA Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer